Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1988 3
1989 1
1990 1
1991 5
1992 2
1993 5
1994 6
1995 3
1996 2
1997 6
1998 2
1999 5
2000 5
2001 3
2002 3
2003 8
2004 5
2005 7
2006 5
2007 11
2008 12
2009 7
2010 5
2011 11
2012 10
2013 19
2014 7
2015 10
2016 13
2017 11
2018 11
2019 16
2020 21
2021 18
2022 18
2023 25
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

266 results

Results by year

Filters applied: . Clear all
Page 1
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.
Cutler C, Lee SJ, Arai S, Rotta M, Zoghi B, Lazaryan A, Ramakrishnan A, DeFilipp Z, Salhotra A, Chai-Ho W, Mehta R, Wang T, Arora M, Pusic I, Saad A, Shah NN, Abhyankar S, Bachier C, Galvin J, Im A, Langston A, Liesveld J, Juckett M, Logan A, Schachter L, Alavi A, Howard D, Waksal HW, Ryan J, Eiznhamer D, Aggarwal SK, Ieyoub J, Schueller O, Green L, Yang Z, Krenz H, Jagasia M, Blazar BR, Pavletic S. Cutler C, et al. Among authors: liesveld j. Blood. 2021 Dec 2;138(22):2278-2289. doi: 10.1182/blood.2021012021. Blood. 2021. PMID: 34265047 Free PMC article. Clinical Trial.
NPM 1 Mutations in AML-The Landscape in 2023.
Sharma N, Liesveld JL. Sharma N, et al. Among authors: liesveld jl. Cancers (Basel). 2023 Feb 12;15(4):1177. doi: 10.3390/cancers15041177. Cancers (Basel). 2023. PMID: 36831522 Free PMC article. Review.
Bone marrow failure syndromes.
Liesveld J. Liesveld J. Best Pract Res Clin Haematol. 2021 Jun;34(2):101288. doi: 10.1016/j.beha.2021.101288. Epub 2021 Aug 5. Best Pract Res Clin Haematol. 2021. PMID: 34404531 No abstract available.
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia.
Advani AS, Moseley A, O'Dwyer KM, Wood BL, Park J, Wieduwilt M, Jeyakumar D, Yaghmour G, Atallah EL, Gerds AT, O'Brien SM, Liesveld JL, Othus M, Litzow M, Stone RM, Sharon E, Erba HP. Advani AS, et al. Among authors: liesveld jl. Blood Adv. 2023 Apr 11;7(7):1279-1285. doi: 10.1182/bloodadvances.2022008216. Blood Adv. 2023. PMID: 36322825 Free PMC article.
Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.
Halliley JL, Tipton CM, Liesveld J, Rosenberg AF, Darce J, Gregoretti IV, Popova L, Kaminiski D, Fucile CF, Albizua I, Kyu S, Chiang KY, Bradley KT, Burack R, Slifka M, Hammarlund E, Wu H, Zhao L, Walsh EE, Falsey AR, Randall TD, Cheung WC, Sanz I, Lee FE. Halliley JL, et al. Among authors: liesveld j. Immunity. 2015 Jul 21;43(1):132-45. doi: 10.1016/j.immuni.2015.06.016. Epub 2015 Jul 14. Immunity. 2015. PMID: 26187412 Free PMC article.
BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.
Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, Ashton JM, Pei S, Grose V, O'Dwyer KM, Liesveld JL, Brookes PS, Becker MW, Jordan CT. Lagadinou ED, et al. Among authors: liesveld jl. Cell Stem Cell. 2013 Mar 7;12(3):329-41. doi: 10.1016/j.stem.2012.12.013. Epub 2013 Jan 17. Cell Stem Cell. 2013. PMID: 23333149 Free PMC article.
Second chances - better than none.
Liesveld J. Liesveld J. Haematologica. 2023 Jul 1;108(7):1718-1720. doi: 10.3324/haematol.2022.282441. Haematologica. 2023. PMID: 36601983 Free PMC article. No abstract available.
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203).
Bolaños-Meade J, Reshef R, Fraser R, Fei M, Abhyankar S, Al-Kadhimi Z, Alousi AM, Antin JH, Arai S, Bickett K, Chen YB, Damon LE, Efebera YA, Geller NL, Giralt SA, Hari P, Holtan SG, Horowitz MM, Jacobsohn DA, Jones RJ, Liesveld JL, Logan BR, MacMillan ML, Mielcarek M, Noel P, Pidala J, Porter DL, Pusic I, Sobecks R, Solomon SR, Weisdorf DJ, Wu J, Pasquini MC, Koreth J. Bolaños-Meade J, et al. Among authors: liesveld jl. Lancet Haematol. 2019 Mar;6(3):e132-e143. doi: 10.1016/S2352-3026(18)30221-7. Lancet Haematol. 2019. PMID: 30824040 Free PMC article. Clinical Trial.
Stem cell homing: From physiology to therapeutics.
Liesveld JL, Sharma N, Aljitawi OS. Liesveld JL, et al. Stem Cells. 2020 Oct 1;38(10):1241-1253. doi: 10.1002/stem.3242. Epub 2020 Jul 21. Stem Cells. 2020. PMID: 32526037 Review.
266 results